Catalyst Biosciences Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: South San Francisco CA United States (2003)

Organization Overview

First Clinical Trial
2011
NCT01439971
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Catalyst Biosciences